Artificial Intelligence in Ocular Transcriptomics: Applications of Unsupervised and Supervised Learning
Cells · 26.08.2025 · 14 (17) · 1315
DOI: 10.3390/cells14171315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.08.2025. Verfasst von Catherine Lalman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. Hauptthemen laut MEDLINE: Supervised Machine Learning, Transcriptome, Gene Expression Profiling, Artificial Intelligence. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcriptomic profiling is a powerful tool for dissecting the cellular and molecular complexity of ocular tissues, providing insights into retinal development, corneal disease, macular degeneration, and glaucoma. With the expansion of microarray, bulk RNA sequencing (RNA-seq), and single-cell RNA-seq technologies, artificial intelligence (AI) has emerged as a key strategy for analyzing high-dimensional gene expression data. This review synthesizes AI-enabled transcriptomic studies in ophthalmology from 2019 to 2025, highlighting how supervised and unsupervised machine learning (ML) methods have advanced biomarker discovery, cell type classification, and eye development and ocular disease modeling. Here, we discuss unsupervised techniques, such as principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), uniform manifold approximation and projection (UMAP), and weighted gene co-expression network analysis (WGCNA), now the standard in single-cell workflows. Supervised approaches are also discussed, including the least absolute shrinkage and selection operator (LASSO), support vector machines (SVMs), and random forests (RFs), and their utility in identifying diagnostic and prognostic markers in age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma, keratoconus, thyroid eye disease, and posterior capsule opacification (PCO), as well as deep learning frameworks, such as variational autoencoders and neural networks that support multi-omics integration. Despite challenges in interpretability and standardization, explainable AI and multimodal approaches offer promising avenues for advancing precision ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Department of Electrical and Computer Engineering, Western University, London, ON N6A 3K7, Canada.
- Department of Ophthalmology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
ORCID-Profile: Janice L Walker
Zitieren
APA
Lalman, C., Yang, Y., & Walker, J. L. (2025). Artificial Intelligence in Ocular Transcriptomics: Applications of Unsupervised and Supervised Learning. Cells, 14(17), 1315. https://doi.org/10.3390/cells14171315
Vancouver
Lalman C, Yang Y, Walker JL. Artificial Intelligence in Ocular Transcriptomics: Applications of Unsupervised and Supervised Learning. Cells. 2025;14(17):1315. doi:10.3390/cells14171315
BibTeX
@article{Lalman2025,
author = {Lalman, Catherine and Yang, Yimin and Walker, Janice L},
title = {Artificial Intelligence in Ocular Transcriptomics: Applications of Unsupervised and Supervised Learning},
journal = {Cells},
year = {2025},
volume = {14},
number = {17},
pages = {1315},
doi = {10.3390/cells14171315}
}
EUVIMED